Zobrazeno 1 - 2
of 2
pro vyhledávání: '"Zhendong Chen"'
Autor:
Zhenggang Ren, Xiao Zhang, Ying Liu, Linna Wang, Jianping Xiong, Hui Li, Jianjun Zou, Xiaojing Zhang, Shukui Qin, Zhendong Chen, Zhiqiang Meng
Publikováno v:
Drug Design, Development and Therapy
Hui Li,1,* Shukui Qin,1,* Ying Liu,2 Zhendong Chen,3 Zhenggang Ren,4 Jianping Xiong,5 Zhiqiang Meng,6 Xiao Zhang,7 Linna Wang,7 Xiaojing Zhang,7 Jianjun Zou7 1Department of Medical Oncology Center, Bayi Affiliated Hospital, Nanjing University of Chin
Publikováno v:
Journal for ImmunoTherapy of Cancer, Vol 9, Iss 3 (2021)
Journal for Immunotherapy of Cancer
Journal for Immunotherapy of Cancer
BackgroundEmerging clinical data suggest that an immune checkpoint inhibitor in combination with an antiangiogenic agent is a reasonable strategy for multiple malignancies. We assessed the combination of camrelizumab with apatinib in pretreated advan